about
The epidemiology of AIDS in Haiti refutes the claims of Gilbert et alCorrelation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility resultsWhole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance EscalationMortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanThe HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.Molecular insights into the evolutionary pathway of Vibrio cholerae O1 atypical El Tor variants.HIV-1 epidemic in the Caribbean is dominated by subtype B.Pre-earthquake non-epidemic Vibrio cholerae in Haiti.Multiple determinants, common vulnerabilities, and creative responses: addressing the AIDS pandemic in diverse populations globally.AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, HaitiCost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.Improving outcomes in infants of HIV-infected women in a developing country settingClinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti.Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti.Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiTreatment outcomes for patients with multidrug-resistant tuberculosis in post-earthquake Port-au-Prince, Haiti.High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.Embracing oral cholera vaccine--shifting response to cholera.Serologic imprint of dengue virus in urban Haiti: characterization of humoral immunity to dengue in infants and young children"I am proud of myself, just the way I am" (Mwen fyé de tét mwen, jan mwen ye ya): a qualitative study among young Haitian women seeking care for sexually transmitted infections (STIs) in Haiti.Molecular characterization and drug resistance patterns of strains of Mycobacterium tuberculosis isolated from patients in an AIDS counseling center in Port-au-Prince, Haiti: a 1-year study.Adapting and Implementing a Community Program to Improve Retention in Care among Patients with HIV in Southern Haiti: "Group of 6"Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settingsHigh-throughput mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping for Mycobacterium tuberculosis epidemiological studiesSnapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study.Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.Ten questions institutional review boards should ask when reviewing international clinical research protocols.The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000.Depression in caregivers of status-naïve pediatric HIV patients participating in a status disclosure study in Haiti and the Dominican Republic: preliminary report.Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-Prince.Rapid-Testing Technology and Systems Improvement for the Elimination of Congenital Syphilis in Haiti: Overcoming the "Technology to Systems Gap".Knowledge, Attitudes, Practices and Beliefs about Medical Male Circumcision (MMC) among a Sample of Health Care Providers in Haiti
P50
Q28114671-F2DB02E4-BE5D-4C2E-ABBC-EBA206A0C062Q28540488-0E1A8E37-E99A-4B58-BC89-11746C85C560Q28547769-B877FF75-8299-4AFD-817A-EA0DF232368FQ28647212-AEF7ECDF-A989-4605-9B33-53E8E9D45C6AQ28741673-68CD58A6-1BDA-462B-B704-E8F2E02AAA8BQ28749991-AA1B4D1B-D7E6-40C6-AC3B-D6C8B986FA2AQ30228985-E079B117-6EAF-49CA-99E3-BF5320F246E0Q30366933-A123FDD9-94FF-49C4-8164-35EE38BBC11DQ30375505-51243479-E274-42D7-857A-B8F09D128F44Q30410259-46E23248-F7DF-4209-808C-E8EFD7E477F2Q30418933-086152C9-C711-4810-A8F4-BFC0B28F012FQ30426578-F02E6FB6-3B50-4E5B-B235-E84D9C470134Q30438405-5D539FC1-3102-4441-BF6F-4C312C4E6213Q33286065-800CF88F-BD90-43C1-A404-46E11D8C403BQ33384449-D8BCA61E-7476-44FA-B220-34727582C0DBQ33390898-53C25DC6-C6E6-4493-A282-4B9D605B6123Q33559528-25ACC96C-1BCE-40FE-94FB-34F8E64653E6Q33596613-E560FC16-F3E6-423A-A371-D4A3C34A5A7AQ33598309-16ADE746-C9DF-4F37-936A-1935B7EE44EBQ33834625-17FAF724-8946-4C73-B93D-ECABB77ECD22Q33909980-CC42EB2C-7362-4F8D-B3DB-B33855CA260BQ34031173-5261A642-5D50-49B1-BDAB-CA27A962D570Q34281547-B783B188-783C-4083-955D-1DA4A955DAFBQ34444002-B5022A8F-89A4-4BEE-8841-C74B73007812Q34662079-0A4E2421-B2B9-4BA6-B46F-0AEB4D7C2DFDQ34707858-6D13235D-23DF-4C1F-9643-EDE28E5A6945Q34729715-108F0974-AF30-4131-B315-AD44D8447A6CQ34751718-C6C7510A-1362-4374-823E-B9F0DA67FD3AQ34762713-24E0C143-C52D-425C-B007-E7988ED39D92Q34775595-6200E5AF-62A2-4315-97B0-77068AEA0164Q34978379-7364F5AC-ABD0-4E8C-8E6D-599BE1812EDEQ34983053-7CC61EA3-68C8-4830-BE2C-37ADED2C5177Q34991344-98228A27-1322-44EA-BBB5-E971E15130C4Q34997183-96BD0E12-E186-4687-8CE8-A0E264F23355Q35166146-96D319F4-A83E-41D6-B5B0-4DD5016CF3ADQ35180426-B3788028-13CC-4B6B-B42B-5FD868F78ECCQ35221303-24B71434-0052-477A-8C0E-F36D325AE6C1Q35381870-2F3FC3E3-BBBB-4D61-91AA-D15ADEE9CFC8Q35623736-8769B195-BAAE-48A9-8634-D74E076D85B6Q35734893-98BB8552-2924-49FF-A5B1-F2EF182D485A
P50
name
Jean William Pape
@en
type
label
Jean William Pape
@en
prefLabel
Jean William Pape
@en